Long term disease modification using immunostimulatory oligonucleotides

Details for Australian Patent Application No. 2009246169 (hide)

Owner Dynavax Technologies Corporation

Inventors Hessel, Edith M.; Coffman, Robert L.

Agent FB Rice

Pub. Number AU-A-2009246169

PCT Pub. Number WO2009/140626

Priority 61/053,605 15.05.08 US

Filing date 15 May 2009

Wipo publication date 19 November 2009

International Classifications

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

A61K 31/7088 (2006.01) - Compounds having three or more nucleosides or nucleotides

A61K 39/00 (2006.01) Medicinal preparations containing antigens or antibodies

A61P 37/00 (2006.01) Drugs for immunological or allergic disorders

Event Publications

9 December 2010 PCT application entered the National Phase

  PCT publication WO2009/140626 Priority application(s): WO2009/140626

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009246176-Spatial interference mitigation for wireless communication

2009246167-Glucokinase activators